Inspire Medical reports Q3 revenue decline and cites $120 million reimbursement headwinds
Inspire Medical Systems posted third‑quarter 2026 revenue of $206.7 million, a 7.9% year‑over‑year drop but a 3.0% sequential increase. Management highlighted coding and reimbursement disruptions as the main near‑term challenge and estimated $120 million in 2026 coding and reimbursement headwinds. The company reaffirmed full‑year 2026 revenue guidance of $850 million‑$860 million, below 2025 levels, and GAAP operating losses widened despite an 86% gross margin.
Why it matters
The revenue decline and sizable reimbursement headwinds suggest pressure on future profitability and margins, which could affect investor expectations for earnings. The lowered full‑year revenue guidance signals a slower growth trajectory for the remainder of 2026.
Key facts
- 1Q3 2026 revenue was $206.7 million. investing.com
- 2Revenue fell 7.9% year‑over‑year. investing.com
- 3Revenue rose 3.0% sequentially. investing.com
- 4Shares rose 1.83% in after‑hours trading following the release. investing.com
- 5Full‑year 2026 revenue guidance is $850 million‑$860 million. investing.com
- 6Management estimates $120 million in coding and reimbursement headwinds for 2026. finance.yahoo.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.